Johnson & Johnson to Test a Pioneering HIV Vaccine: Brainstorm Health

Happy Friday, readers! Johnson & Johnson doesn’t just want to treat HIV—it wants to prevent against it altogether with an experimental vaccine. The U.S. drug giant announced Friday that will test out the vaccine in the U.S. and Europe this year, according to CNBC. If it proves successful—following testing on thousands of men who have […]

What AbbVie’s $63 Billion Deal to Buy Allergan Says About the Drug Industry

AbbVie announced on Tuesday that it will buy Allergan in a deal valued at about $63 billion, a 45% premium on Allergan’s most recent closing stock price. The proposed M&A will be one of the largest health care mergers of the year and bring together a portfolio that includes AbbVie’s Humira, the world’s best-selling drug, […]

How This Biotech Wants to Become a Stem Cell Therapy Success Story

The world of stem cell-based medicine has had its fair share of disappointments and regulatory recriminations over wildly inflated claims. But Athersys CEO Gil Van Bokkelen says the stem cell field isn’t getting a fair shake. “It’s a misconception to say stem cells haven’t really delivered,” he tells Fortune in an interview. “This is a […]

Rakuten’s CEO Is Developing a Brilliant New Cancer Treatment: Light

Some types of innovation are fueled by curiosity. Others stem from the profit motive. (In many cases, it’s a bit of both). For Rakuten CEO Mickey Mikitani, the quest for groundbreaking science was born of heartbreak. Mikitani’s father’s pancreatic cancer diagnosis (and eventual death) spurred the serial entrepreneur to form a biotechnology outfit centered on […]